Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7
Frequently Asked Questions
What is Market Cap of Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) market cap is $121.5M.
What is the 52-week high for Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) 52 week high is $18.15 as of October 27, 2025.
What is the 52-week low for Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) 52 week low is $9.54 as of October 27, 2025.
What is Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) stock price today?
Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) stock price today is $13.25.
What was Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) stock price yesterday?
Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) stock price yesterday was $9.60.
What is the PE ratio of Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)’s P/E ratio is 20.80.
What is the Price-to-Book ratio of Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) P/B ratio is 2.2857.
What is Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)'s EBITDA is N/A.
What is the 50-day moving average of Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) 50-day moving average is $10.17.
How many employess does Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) has?
Coeptis Therapeutics Holdings Inc - Unit (1 Ordinary share & 1 War) has 7 employees.
